Subscribe and get detailed information

BIOSIMILARS CONGRESS INDIA 2018

Be the first one to think different In the market of Biosimilars


The impact of two key events- a phase of unprecedented patent expiration on many of the blockbuster biologics and financial crisis demanding significant and sustained cost reductions in the healthcare market is constantly changing the global Biosimilars landscape. The biosimilar is a lucrative sector owing to recent regulatory approvals and increasing opportunities. Biosimilars are at different stages of evolution across the globe. Developing a biosimilars demands huge investment, technical capabilities and clinical trial expertise. In order to unlock the biosimilars potential, the industry will entail focused strategies along the whole value chain, from optimizing the clinical development program to commercialization.

In this limelight, CPhI Conferences is pleased to announce the 3rd Annual Biosimilars Congress India 2018 conference on 23rd - 24th August 2018 in Hyderabad. This conference will congregate top industry stalwarts to discuss key challenges and best practices from development to launch of Biosimilars.

MEET THE ADVISORY BOARD MEMBERS AND SPEAKERS

KEY TOPICS OF DISCUSSION

Dynamics of Biosimilars and its Relevance-India

Overview on Biosimilars and Prospects for the Future

Regulatory Perspective: Biosimilars

Analytical Approaches for Efficient Upstream and Downstream Process Development

Clinical Development Strategies for Biosimilars

R&D, Manufacturing and Process Development

Pharmacovigilance of Biosimilars

"How Late is Too Late": Challenges for New Entrants

Global Development Strategy on Biosimilars: How to Win in the International Space

Product Development Alliances for Biosimilars

Managing Costs and Technology Adoption in Biosimilar Development

What's next for Biosimilars: New Biological Entity/ Bio-betters

Marketing of Biosimilars: Commodity versus Differentiated

KEY FEATURES

  • Meet Regulatory Expectations
    Understand the FDA expectations on Biosimilars interchangeability and updates on the EMA guidelines for approval of Biosimilars
  • Devise Strategies
    Explore different statistical approaches to demonstrate biosimilarity with the reference product
  • Panel Discussion and Extended Q&A Sessions
    Open forum to discuss your most critical questions around Biosimilars
  • National & International Speakers
    Network with national and international industry stalwarts who will inspire, educate and engage.
  • Practical Case Studies
    Gain insights and enhance your knowledge with practical case studies addressed at this esteemed summit.

ATTENDEE PROFILE

Industries / Categories

Bio-Pharmaceuticals

Biotech

Pharmaceuticals

Life Sciences

Designation

CEO's and MD [Small-scale organizations], Vice Presidents, Associate Vice Presidents, Directors, Associate Directors, HOD, Deputy General Manager, General Manager, Senior Managers, Managers, Assistant Managers, Senior Executives, Executives, Scientists

Departments

Bioanalytical, Biosimilars, Biotech, Clinical research, Manufacturing - upstream, downstream, Regulatory, Quality Assurance, Quality Control, Production, R&D

EVENT PARTNERS

Cocktail Partner

Silver Partners

Associate Partners

Exhibit Partners

Knowledge Partner

Supporting Associations

Media Partners